EMEA-000978-PIP01-10-M01
Key facts
Invented name |
Zelboraf
|
Active substance |
vemurafenib
|
Therapeutic area |
Oncology
|
Decision number |
P/0210/2016
|
PIP number |
EMEA-000978-PIP01-10-M01
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of melanoma
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Roche Registration Limited
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|